Publication Year

Proctor DM, Suh M, Tachovsky JA, Abraham L, Hixon JG, Brorby GP, Campleman SL. Cumulative risk assessment of urban air toxics: A pilot study in San Antonio, Texas. Presented at Society of Toxicology 53rd Annual Meeting, Phoenix, AZ, March 2014.

Faber W, Kirkpatrick D, Coder P, Li P, Borghoff S, Banton M. 2014. Subchronic, reproductive, and maternal toxicity studies with tertiary butyl acetate (TBAC). Regul Toxicol Pharmacol 68:332-342.

Jensen IS, Bay C, Cyr PL. Estimating the impact of combining cangrelor and bivalirudin to a U.S. hospital performing PCI procedures. ISPOR 18^th Annual International Meeting, New Montreal Quebec, 2014.

Pinto DS, Nicholson G, Harrington RA, Cyr PL, Bhatt DL. CHAMPION PHOENIX Study economic results: Direct hospitalization costs of patients receiving clopidogrel or cangralor during percutaneous coronary intervention. American Heart Association QCOR conference, Baltimore, MD, 2014.

Jensen IS, Wu C, Bay CB, Cyr PL. Estimating the clinical value of cangrelor in patients undergoing PCI. International Academy of Cardiology, 19th World Congress on Heart Disease, Boston, MA, 2014.

Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL, Jensen IS. A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16^th Annual European Congress, Amsterdam, Netherlands, 2014.

Bay C, Cyr PL, Jensen IS. Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.

Christian WV, Oliver LD, Paustenbach DJ, Kreider ML, Finley BL. 2014. Toxicology-based cancer causation analysis of CoCr-containing hip implants: A quantitative assessment of genotoxicity and tumorigenicity studies. J Appl Toxicol 34(9):939–967.

Paustenbach D, Galbraith D, Finley B. 2014. Letter to the Editor: Authors’ response to letters to the editor re: Interpreting cobalt blood concentrations in hip implant patients. Clin Toxicol 52(5):569–570.

Finley BL, Scott PK. 2014. Diacetyl and “popcorn lung” litigation: Assessing the evidence for general causation. ABA Environ Litigation Toxic Torts Newsletter 15(2):7–10.

Kerger BD, Thuett KA, Finley BL. 2014. Evaluation of four a-diketones for toll-like receptor-4 (TLR-4) activation in a human transfected cell line. Food Chem Toxicol 74:117–119.

Dingley KH, Ubick EA, Vogel JS, Ognibene TJ, Malfatti MA, Kulp K, Haack KW. 2014. DNA isolation and sample preparation for quantification of adduct levels by accelerator mass spectrometry. Methods Mol Biol 1105:147–157; doi: 10.1007/978-1-62703-739-6_12. PMID: 24623226.

Moyes CR, Berger R, Goble SD, Harper B, Shen DM, Wang L, … Dingley KH, et al. 2014. Design, synthesis, and evaluation of conformationally restricted acetanilides as potent and selective β3 adrenergic receptor agonists for the treatment of overactive bladder. J Med Chem 57(4):1437–1453; doi: 10.1021/jm4017224. PMID: 24437735.

Paustenbach DJ, Galbraith DA, Finley BL. 2014. Interpreting cobalt blood concentrations in hip implant patients. Clin Toxicol 52(2):98–112; doi: 10.3109/15563650.2013.857024. PMID: 24256093.

Pierce JS, Abelmann A, SpicerLJ, Adams RE, Finley BL. 2014. Diacetyl and 2,3-pentanedione exposures associated with cigarette smoking: Implications for risk assessment of food and flavoring workers. Crit Rev Toxicol 44(5):420–435; doi: 10.3109/10408444.2014.882292. PMID: 24635357.

Unice KM, Kerger BD, Paustenbach DJ, Finley BL, Tvermoes BE. 2014. Refined biokinetic model for humans exposed to cobalt dietary supplements and other sources of systemic cobalt exposure. Chem-Biol Interact 216:53–74; doi: 10.1016/j.cbi.2014.04.001. PMID: 24726710.

Monnot AD, Christian WV, Paustenbach DJ, Finley BL. 2014. Correlation of blood Cr(III) and adverse health effects: Application of PBPK modeling to determine non-toxic blood concentrations. Crit Rev Toxicol 44(7):618–637; doi:10.3109/10408444.2014.926472. PMID: 25068491.

Tvermoes BE, Unice KM, Paustenbach DJ, Finley BL, Otani JM, Galbraith DA. 2014. Effects and blood concentrations of cobalt after ingestion of 1 mg/d by human volunteers for 90 d1-3. Am J Clin Nutr 99(3):632–646; doi: 10.3945/ajcn.113.071449. PMID: 24500148.

Beasley TE, Evansky PA, Martin SA, McDaniel KL, Moser VC, Luebke RW, Norwood J Jr, Rogers JM, Copeland C, Bushnell PJ. 2014. Toxicological outcomes in rats exposed to inhaled ethanol during gestation. Neurotoxicol Teratol 45(Sept-Oct):59–69; doi: 10.1016/j.ntt.2014.07.002.

Daston GP, Beyer BK, Carney EW, Chapin RE, Friedman JM, Piersma AH, Rogers JM, Scialli AR. 2014. Exposure-based validation list for developmental toxicity screening assays. Birth Defects Res B 101(6):423–428; doi: 10.1002/bdrb.21132.